[Federal Register Volume 74, Number 161 (Friday, August 21, 2009)]
[Notices]
[Page 42313]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-20170]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Cancer Institute Director's Consumer Liaison Group.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Cancer Institute Director's Consumer 
Liaison Group.
    Date: October 20-22, 2009.
    Time: October 20, 2009, 2 p.m. to 6 p.m.
    Agenda: Welcome, Overview of the NCI Advanced Therapeutics 
Platform, Expert Panel on NCI Therapeutics Platform.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892.
    Time: October 21, 2009, 8:30 a.m. to 5:30 p.m.
    Agenda: Gaining Community Input on NCI Therapeutics Platform, 
Communicating with the Community About the NCI Therapeutics 
Platform, Advocates in Research Working Group Discussion, NCI 
National Outreach Network Discussion.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892.
    Time: October 22, 2009, 8:30 a.m. to 1 p.m.
    Agenda: Communicating with the Community about the NCI 
Therapeutics Platform (cont'd), Engaging the Community Around the 
NCI Therapeutics Platform, Discussion with NCI Director.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892.
    Contact Person: Benjamin Carollo, MPA, Advocacy Relations 
Manager, Office of Advocacy Relations, Building 31, Room 10A30, 31 
Center Drive, MSC 2580, National Cancer Institute, NIH, DHHS, 
Bethesda, MD 20892-2580. 301-496-0307. <a href="/cdn-cgi/l/email-protection#355654475a59595a577558545c591b5b5c5d1b525a43"><span class="__cf_email__" data-cfemail="1a797b6875767675785a777b737634747372347d756c">[email protected]</span></a>.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page:http://deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: August 17, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-20170 Filed 8-20-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>